Increased modifiable cardiovascular risk factors in patients with Takayasu arteritis: a multicenter cross-sectional study
Open Access
- 8 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Advances in Rheumatology
- Vol. 61 (1), 1-9
- https://doi.org/10.1186/s42358-020-00157-1
Abstract
Modifiable cardiovascular risk factors (MCRFs), such as those related to aerobic capacity, muscle strength, physical activity, and body composition, have been poorly studied in Takayasu arteritis (TAK). Therefore, the aim of the study was to investigate MCRFs and their relationships with disease status and comorbidities among patients with TAK. A multicenter cross-sectional study was conducted between 2019 and 2020, in which 20 adult women with TAK were compared with 16 healthy controls matched by gender, age, and body mass index. The following parameters were analyzed: aerobic capacity by cardiopulmonary test; muscle function by timed-stands test, timed up-and-go test, and handgrip test; muscle strength by one-repetition maximum test and handgrip test; body composition by densitometry; physical activity and metabolic equivalent by IPAQ, quality of life by HAQ and SF-36; disease activity by ITAS2010 and NIH score; and presence of comorbidities. Patients with TAK had a mean age of 41.5 (38.0–46.3) years, disease duration of 16.0 (9.5–20.0) years, and a mean BMI of 27.7±4.5 kg/m2. Three out of the 20 patients with TAK had active disease. Regarding comorbidities, 16 patients had systemic arterial hypertension, 11 had dyslipidemia, and two had type 2 diabetes mellitus, while the control group had no comorbidities. TAK had a significant reduction in aerobic capacity (absolute and relative VO2 peak), muscle strength in the lower limbs, increased visceral adipose tissue, waist-to-hip ratio, reduced walking capacity, decreased weekly metabolic equivalent, and quality of life (P< 0.05) as compared to controls. However, there were no correlations between these MCRFs parameters and disease activity. TAK show impairment in MCRFs; therefore, strategies able to improve MCRF should be considered in this disease.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo ((#2018/08735-3, (#2019/12155-5, #2019/11367-9)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (#303379/2018-9)
- Faculdade de Medicina da USP - SP (.)
This publication has 56 references indexed in Scilit:
- Body Fat Distribution, Incident Cardiovascular Disease, Cancer, and All-Cause MortalityJournal of the American College of Cardiology, 2013
- Measuring Adiposity in Patients: The Utility of Body Mass Index (BMI), Percent Body Fat, and LeptinPLOS ONE, 2012
- Role of Adipokines in Atherosclerosis: Interferences with Cardiovascular Complications in Rheumatic DiseasesMediators of Inflammation, 2012
- The epidemiology of subclavian stenosis and its association with markers of subclinical atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA)Atherosclerosis, 2010
- Cardiorespiratory Fitness as a Quantitative Predictor of All-Cause Mortality and Cardiovascular Events in Healthy Men and WomenJAMA, 2009
- Lack of Antilipoprotein Lipase Antibodies in Takayasu's ArteritisJournal of Immunology Research, 2009
- Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary diseaseThorax, 2007
- Trends in incidence and clinical presentation of temporal arteritis in olmsted county, minnesota, 1950–1985Arthritis & Rheumatism, 1988
- Assessing Disability in Patients with Rheumatoid ArthritisScandinavian Journal of Rheumatology, 1988
- Takayasu's arteritis. Clinical study of 107 casesAmerican Heart Journal, 1977